WINDTREE THERAPEUTICS INC /DE/ Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $1.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2025-04-15
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $1.00M, a 64.29% decline from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $2.80M, a 26.32% decline from fiscal 2022.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $3.80M, a 43.28% decline from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2021 was $6.70M, a 5.63% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month as first filed |
|---|---|---|
| 2024-12-31 | $1.00M 10-K · filed 2025-04-15 | |
| 2023-12-31 | $2.80M 10-K · filed 2025-04-15 | |
| 2022-12-31 | $3.80M 10-K · filed 2024-04-16 | |
| 2021-12-31 | $6.70M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $7.10M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $5.60M 10-K · filed 2021-03-29 | |
| 2018-12-31 | $600.00K 10-K · filed 2020-04-03 | |
| 2017-12-31 | $1.90M 10-K/A · filed 2019-04-23 | $3.10M 10-K · filed 2018-04-17 |
| 2016-12-31 | $1.90M 10-K · filed 2018-04-17 | |
| 2015-12-31 | $2.70M 10-K · filed 2017-03-31 | |
| 2014-12-31 | $3.10M 10-K · filed 2016-03-29 | |
| 2013-12-31 | $1.90M 10-K · filed 2015-03-16 | |
| 2012-12-31 | $2.20M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |